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1289~ 'Ί 90/44 (9 3 antigen) in Τ cell activation
T90/44 (9.3 antigen). Α cell surface molecule with a
function in human Τ cell activation*
T90/44 IS a cell surface antigen which IS present on human Τ cells of the helper and
cytotoxic subsets and which binds the 9 3 monoclonal antibody (9 3'mAb) It is
expressed in the form of 90-kDa disulfide-bonded dimers of a 44-kDa polypeptide and
of free 44-kDa subumts The function of T90/44 was investigated in a senes of Τ cell
function assays 9 3 mAb was found to mhibit the activation of class II-restncted
cloned Τ helper cells denved from leprosy patients and reactive with Μ leprae anti-
gens The Inhibition was first found at 1-10 ng/ml 9 3 mAb and regularly increased
with the antibody concentration The extent of the Inhibition vaned among different
Τ cell clones in proportion to the respective different levels of T90/44 expression at
their cell surface The prohferative responses of penpheral blood lymphocytes (PBL)
to punfied protein derivative of Μ tubertulosis (PPD) and tetanus toxoid were
enhanced by the 9 3 mAb resulting in up to 20-30-fold increase of [3H]-thymidme
incorporation After phytohemagglutinm-induced activation of PBL, the number of
T90/44 molecules per cell expressed at the cell surface rose from day 0 to day 7 by a
factor of about 10 High concentrations of 9 3 mAb (5-10 \iglm\) at low cell densities
and in the presence of monocytes in culture media supplemented by fetal calf serum
were directly mitogemc for resting lymphocytes The cytolytic effector functions of
class I-restncted cytotoxic Τ lymphocytes (CTL) were not modulated by 9 3 mAb
The mixed lymphocyte reactions of three class I-restncted CTL to their specific target
cells were found not to be significantly mfluenced by 9 3 mAb In conclusion it is
proposed that an antigen-independent Τ cell activation pathway can be entered at
T90/44
1 Introduction
The activation of Τ cells to differentiate and to prohferate are
essential Steps in the immune response to antigen This funda-
mental property of the immune System correlates with the in
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Abbreviations: APC: Antigen presenting ccll(s) CML: Ccll-medi
ated-Lympholysib CTL: Cytotoxic Τ cells EBV-BCL: Epstein-Barr
virus-transformed Β cell hnes FACS: Fluorescence activated cell sor
ter FCS: Inacüvated letal calf serum FITC: Fluorescein isothiocy
anate HA-3: Minor histocompatibüity antigen HA-3 HS: Heat-
mactivated human pooled AB serum H-Y: Male specific minor his
tocompatibihty antigen IMDM: Iscove's modified Dulbecco's
medium mAb: Monoclonal antibody(ies) MHC: Major histocom
patibility complex PBL: Penpheral blood mononuclear cells PBS:
Phosphate buffered sahne PHA: Phytohemagglutimn PPD: Pun
fied protein derivative of Μ luberculous SDS: Sodium dodecyl sul
fate IT: Tetanus toxoid
vitro finding that the tnggenng of the antigen reeeptor Ti/T3-
antigen complex by appropnately presented antigen or by
monoclonal antibodies (mAb) is capable of ehcitmg prolifera-
tive Τ cell responses (for review see [1, 2]) The discovery that
two mAb directed to epitopes of the Tl 1 antigen in combina-
tion also can stimulate Τ cell growth [3] proved that additional,
antigen-independent activation pathways exist More recently,
it was found that yet another class of Τ cell surface molecules,
T90/44, in response to the bmding of a specific hgand, can
dnve Τ cells into prohferation T90/44 binds the 9 3 mAb [4],
it is expressed at the surface of helper (Th) and cytotoxic Τ cell
subsets in the form of 90-kDa disulfide-bonded dimers of a 44-
kDa polypeptide and of free 44-kDa subumts [5-7] The first
indication that T90/44 may function in a new antigen-indepen-
dent Τ cell activation pathway was provided by the discovery
that 9 3 mAb strongly enhances prohferative cell responses to
phytohemagglutimn (PHA) and allogeneic cells [5] This
hypothesis was further supported by the more recent fmdings
that 9 3 mAb also enhances the mitogemc response to 12-0-
tetradecanoylphorbol 13-acetate and may act as a direct mito-
gen [7, 8]
To assess the functional role of T90/44 in more detail, we have
investigated the effects ot 9 3 mAb in cell tulture assays with
cloned antigen-specific helper cells as well as cytotoxic Τ cell
hnes (CTL) and resting normal Τ cells Our results show that
dependmg on the type of the cells in culture, positive or nega-
tive Signals can be mediated through T90/44, since the activa-
tion of helper cells by antigen was found to be inhibited by
9 3 mAb, whereas resting Τ cells may be activated by
9 3 mAb An important element in this functional dichotomy
may be that T90/44 expression is strongly induced in activated
cells The effector function of the CTL could not be influenced
by 9 3 mAb, although they were found lo express T90/44
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2 Materials and methods
2.1 Cells
2.1 I Peripheral blood lymphotytes (PBL) and Epstein-Barr
virus-transformed Β cell lincs (EBV-BCL)
PBL were isolated froni heparimzed venous blood on Ficoll/
Isopaque density gradients washed ( x i ) in Hanks' balanccd
salt soiution (Gibco, Pa>sley, Scotland) and resuspended in
Iscove s modified Dulbecco's medium (IMDM, Gibco) or
RPMI 1640 supplemented wilh streptomycm 100 μ^ιτιΐ,
penicillin 100 U/ml, both from Flow Laboratories, lrvine
Scotland, and 15% poofed human AB serum (HS) or 10%
fetal calf serum (FCS) CBV-BCL were generated trom
5 x 10" autologous PBL accordmg to Steinilz et al [9] Cells
were frozen in 1 m! ampoules contammg Ι χ 10(-^ χ 10f> cells,
707r RPMI 1640 20% screened pooltd human AB plasma
and 10% dimethylsulfoxide and stored at - 196 °C
2.1.2 Antigen reactivation and cloning of 1 lymphocytes
Cloning of Τ iymphocytes was performcd as descnbed else-
where [10 11] In bnef PBL ot two leprosv patients (BC and
R) were restimulated in vitro with Μ leprae m IMDM sup-
plemented with 10% HS dunng 5 days at 37 °C in a fully
humidified 5% COyair mixturc Τ ceil blasts were obtamed
either by Percoll dcnsity centrifugation or by cxtcndmg the
cultures for another 3-10 days in the presence of 10% inter
leukm 2 (IL 2, Lymphocult-T, Biotest, Frankfurt, FRG) The
blasts were cioned under limitmg dilution conditions (0 5 ccll/
well) on a irradiated feeder cell iayer containmg autologous
EBV-BCL as antigen-presenüng cetls (APC), and optimal
concentrations of Μ leprae antigen All cultures were pei-
formed in IMDM suppiemented with 10% HS in 96-well flat-
bottom microtiter plates (Microtest III 3072, Becton Dickin-
son, Sunnyvale, CA) Growing cultures were transferred to
24-well flat-bottom plates {Falton 3047 Becton Dickinson)
and restimulaied with antigen and irradiated feeder cells every
two weeks Ihree days after e.ich antigen feeder icstimula
tion 20% IL 2 was added Ihe cells were fro/cn 3-10 days
after the final restimulation
2.1.3 CTL
The foilowing CTL were used in the cell-mediattd lymphoivsis
(CML) assays and in the prohterative assays (a) Alloimmunc
HLA-A2 1 subtvpe-specific C1L (12] (b) HLA-Al and B8-
restneted minor hislocompatibiiity (minor-H) antigen (( e
minor HA-3)-speciftc CTL [13], and (c) MLA-A2 and/or
HL A-B7-restntted H-Y-speufic CTL [13]
2.2 Surface iodination, immunoprecipitation and f>el
eketrophoresis
All cells were surface lodmated undci carefully standardiztd
conditions essentially as previously repoitcd [5, 6] Bnefly,
viablt cells were isolated from cultures or bufiy coats on Ficoli/
Isopaque density gradients and washed twice in phosphatc-
buffered sahne (PBS) with 1 0 mg/ml glutose The ceils were
resuspended at eithei 5 x l()7 or l()h cells/ml (cioned celis or
PBL icspectively) in PBS with 1 0 mg/ml glucosc and lac-
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toperoxidase (10 μΙ/ml of 1 mg/ml stock soiution), Na12"!
(100 μ θ = 3 7 MBq per 10H ceils) and giueose oxidase (10 μΐ/
ml of Sigma, Munich, FRG, G 6500 diluted 250 x) were
added The labeled cells were washed twice in PBS and lysed
with 0 5% punfied Tuton X-10Ü in 50 mM ins-HCl 150 mM
NaCl, 0 02% NaN-, (pH 7 5) at 5 χ 107 cells/ml for 20 min on
lee The lysate was cleared by centnfugation (400 χ g, 10 mm,
4°C) and stored at -80°C For immunoprecipitation 200 μΐ
aliquols of the cell lysates were precieared with 10 μg punfied
mouse immunoglobuhns (Nordic, Tilburg, The Netherlands)
and precipitated with 2 5-4 3 μg of the specific mAb (30 min
on ice) and 5 μΐ rabbit anti-mouse immunoglobulm (Z 109
Dakopatts, Copenhagen, Denmark 30 min on ice)
Fixed Staph aureus cells (Calbiochem, La Jolla, CA) were
used as immunosoibent Reduced or nonredueed sodium
dodecyl sulfate (SDS) gels were run as previously reported
[5, 6] The gels were stained, dned under vaeuum and exposed
to Kodak XAR-5 films with Dupont Cronex Li-PLus inten-
sifier screens at - 80 °C
2.3 Antigens and antibodics
Μ leprae antigens were kindly provided by Dr Μ Abe (Nat
Inst Leprosy Research, Fokyo Japan) and by Dr R C
Good (Centre for Infectious Diseases, CDC, Atlanta GA)
Both preparations consisted of bacilii isolated from human
tepromas aecording to Dharmendia's proceduie [14J with
siight modifications The end concentrations of the fnsl prepa-
ration m the cultures are given in μg/ml, whereas those of the
second preparation are txpressed as final diiution in the cul-
tures The 9 3 mAb was onginaily prepared by Hansen et al
[4] For the present expenments, the 9 3 mAb was bought
from New Tngland Nuclear (Boston, MA), it was punfied by
protein Α aifinity chromatography and found to bc
homogeneous by SDS gel electrophoresis Other monoclonai
antibodies used were directed against ciass I majoi histocom
patibihty antigen, 9455 SA/BRL, W6/32, B9 12 1 (couitesy of
Dr Β Mahssen), ßi-microglobulm, Bl 1 G 6 (courtesy of Di
Β Mahssen), T3 antigen W132(RIV Bilthoven), T4, RIV6
Γ8, IK18, transferrm reeeptor, 6 Κ 22 1, I F Α 1, 8 3 14 1,
DR, B8 11 2 (courtesy Dr Β Mahssen), DQ, SP V L3 8
(courtesy Dr Η Spits), 3Al-hke determmant, 64 5 1 and
Ob,, PdV 10 2
Goat anti-mouse fluorescein isothiocyanate(FITC)-conju-
gated immunoglobulm was purchased from Nordic Unless
otherwise specified, all antibodies were used at previously
determined optimal concentrations
2.4 Cellular assays
2.4.1 Activation of cioned human Τ helper cells by Μ leprae
One x 10l TLC and 5 χ ΙΟ4 irradiated (40 Gy) autologous or
HLA class 11-matched peripheral blood lymphocytes (PBL) as
APC in IMDM with 10% HS woie eultured with Μ leprae
antigen in optimal concentrations m 96-well flat bottom mi-
crotiter plates (Greincr, Nuningen, FRG) Phytohemaggluti-
nin (ΡΠΑ, Wellcome Diagnostits, Beckenham, GB, 4 \x,gln\\)
and piain IMDM were used as controls 9 3 mAb was taken up
m RPMI 1640 with 20% HS and diaiyzed against RPMI 1640
Vanous amounts of the dialy/ed antibody were added to the
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cultures calculated to give fmdl concentrations ranging from
0 001-10 μ^ΐηΐ antibody
The cultures were set up in duphcate or tnplictte and incu
bated as dexcnbed above for 72 h Eighteen hours bcforc tci
mination 1 0 μ θ = 17 kBq of [methyl ^Hjthymidinc
([ HjdThd spec act 5 0 Ci/mmol Radiochemical Centrc
Amersham, GB) in 0 05 ml RPMI 1640 was added The s im
ples were harvested on glass fiber filteis using a semi automa
tic device [3H]dThd incorporation was assessed by liquid sein
tillation counting As a control parallel cultuies were set up
with the anti 3A1 like antibody 6 4 5 1 in comparable dilution
directly from pure ascites
2 4.2 Mixed lymphocyte eulture (MLC)
MLC were sei up by eultunng 50000 responder and 50 000
irradiated (2000 rds) stimulator cells in V well microtiter trays
in 0 15 ml of RPMI 1640 supplemcnted with 15% pooled
human AB serum and 50 μ^ΐηΐ gentamyem (Flow Lab
Irvmt ScotlanJ) The cells were eultured for 120 h, 18 h
before harveoting, 1 μ θ of pH]dThd was added to each eul
ture Antibodies were added dt the stait of the MLC and lefl
throughout the eulture penod
2 4.3 Lymphocyte transformation ttsts
Lymphocyte iiansformation tests wert, earritd out as tollows
50000 responder cells (PBL or fluorescence acü\ated cell soi
ter (FACS) sepaiated cells) weie eulturtd in flat bottom mi
crotitertrays in 0 15 ml/well of tissue eulture mtdium
(RPMi 1640, gentamycin 50 μg/ml 15% HS) contaimng
either 5 μ§/ΐτι1 punfied protcin derivative of tubereuhn (PPD
Statens Serum Institute Copenhagen) 0 75 l l/ml tet inus to\
oid (TT, RIV Biithoven The Netherlands) oi 5 μο/ml PHA
Cultuie, incubation time and fHjdThd incorporation were
carned out d& desenbed in Sect 2 4 2 PBL activated by PHA
to bc labeled and lmrnunoprecipitated at dav 0 3 5 7 wert
treated as above but 20% lnterlcukin 2 (IL 2) was .idded to
the medium aftcr d ty 3
2 4 4 Cell-mediated lympholysis (CML) assay
The alloimmune and the MHC testnetuf CTL populatioris
were generated aecording to the eulture pioceduies desenbed
earher [12 Π] The effector cells weie pre incubatcu for
30 min with three different coneentiations of the 9 Ί mAb
before addition of the specific target cells The CML a sij has
been desenbed in detail [13 15] The percentages oflysis were
determined in lelation to PHA stimulated blast cehs in a 4 h
5 lCr assay Cytotoxieity (ι e tht amount of isotepe reltased
from 5 lCr labeled target cells) was determined and calculated
aecordmg to the desenbed method [Π] Standard errors of the
mean of tuplicate determinations were less than 5% Positive
and negative assignments were made on the Msis of a 10%
speeific MCr reltase value All expenments weit repealed U
least twice at different effeetor to target latios
2.5 Indirect lmmunofluorestence and I-ACS analysis
Analysis of mdireet surface immunofluorescence and eell sort
ing were carned out with a l ACS IV (Becton Dickinson Sun
nyvale CA) as reported elsewheie [16]
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3 Results and discussion
3.1 Inhibition of response to antigen of cloned Th telJs
Class II restneted eloned T h ceils specitie ior Μ kprai mtt
gens weie denved from lepiosj patients as prc\ IOLISIJ leport td
[10 11] The aetivation of a number oi these Γ eell clones b>
Μ leprae as a funetion of the 9 3 mAb m the eoncentr ition
ränge of 0 001-10 μς/mi was me isuied bv mcoipot ition oi
[ 3 II]dThd into macromolecui ir nucleic aeicls It w is lound th it
the 9 3 mAb stiongly mhibited the intigen lesponses in some
of these clones (e g clones 4A4 2F9 2FI0) uhereas the inhi
bition in other clonts was weak fi i* elone 6C 7) oi pi ictie ilK
absent (clone 2G11 see fig 1) In these l i tter cases mhibi
tion was observed onlj it veiy hieh 9 3 mAb concuiti ition In
the strongly mhibited clones the inhibitui\ ettcet v\ is lirst
observed at ng/ml 9 3 mAb and regularlv meieased with the
antibody concentration Ί he pr tcticalH const mt n. i ; iti\e
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slope of the dose response curve in these clones contrasts sig
mficantly with the practically antibody indepcndenl responses
in parallel cultures with the 6 4 5 1 mAb which for the pur
pose of the prtsent investigation may be considered as an
irrelevant control antibody of the same IgG subclass as the
9 3 mAb The negative result of this latter controi expenment
allows to rule out that the effect of 9 3 mAb is due to tnvnl
phenomena such as antibody dependent cytotoxicity
All curvts in Fig 1 rcprestnt independent exptnments which
have been carned out dunng a penod of about one year
Within that penod the extent to which a given clonc responded
to the inhibitory eftect of the 9 3 mAb in the Μ leprae stimu
lation assay was found to be reproducible the response to the
9 3 mAb thus appears to be a specific and stable property of
the individual clones at least withm that penod It is worth
noting that all these clones in functional assiys behave as class
II restncted T h cells [10 11] furthermore they all respond
well to mitogenic Stimulation by PHA (dita not shown) The
different responses in the assays presented in Fig 1 therefore
ire not due to differences in the gtneral prolifcr itivc potenti \\
among the clones
3 2 9 3 mAb Inhibition of Μ leprae activation is proportional
to Γ90/44 expression of the different Th cell clones
To discover the cause of the vanabihty in the 9 3 mAb depen
dent Inhibition of the activation by Μ leprae among the differ
ent cell clones the level of expression of T90/44 and of a
number of refercnce antigens was mvestigated I ysatcs of sur
face lodina ed cells were sequentially immunoprecipitated
with a panel of mAb the immunoprecipitates were then iden
tified in SDS gels by autoradiography as indicated in Fig 2
the bands were cut from the gels and the incorporated radioac
tivity was counted (Fig 3) To evaluate the dita in Fig 3
LFA 1 should be considered first
In a senes of prelimmary expenments it hid becn found th it
the level of expression of I FA 1 when compired to that of
other surface antigens is the most constant imong the difrerent
cell clones This conclusion is confirmed by f ig 3 Α mean of
18000 (±6300) cpm are incorporitcd in the 1 irge subunit of
A B C D Ε F
92- # ' Ψ
45- * ~ ·
3 1 -
2 1 -
^^ 625 2 Π
htgurt 2 Immunoprecipitated T9Ü/44 and HI Λ cl iss I mülecules
(A) clone 4A4 T90/44 nonreduced (B) clonc 4A4 r9U/44aftcrrtdut
lion of disulfide bonds (C) clonc 2Gll 190 44 nonreduced (D)
clonc 6C7 HLA class I (E) PBL T90/44 nonrcductd (F) PBL ΓΟΟ/
44 after reducnon of disulfiüc bonds Ihc precipitatcs in (A) (D)
rcprcsent ceil ahquots of !07 cells The precipitatcs in (b) (F) repre
sent > !0N cells For the measurement of incorponted ndiol ibel the
bands were cut out is indic ued by broken hncs
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LFA iperS x 107 cells of the diffei ent clones The amount of
radiolabel in the small subunits are simiUrly constant so thit
the ratio of radiolabel in the two subunits is 4 67 ± 0 54
The remarkable constancy of LFA 1 expression is in contrast
to the FiLA class I molecules whcre large vanations among
the different clones are found It is noteworthy however that
HLA heavy chain and ß2 microglobulm vary to the same
degree the ratio of the radiolabel incorporated in the heavy
and light chains respectively is 2 59 ± 0 49 for the 6 cell
clones These results support the conclusion that Fig 3 reh
ably represtnts the relative level of expression of the surface
antigens when the different cell dones are compared
it appears from these data that the Inhibition by 9 3 mAb of
the Μ leprae activation correlates well with the level of T90/44
expression in a given clone This is most clearly seen by com
panng dones 2B2 or 2F10 with clone 2G11 Clones 2B2 and
2F10 express high levels of T90/44 (5900/4300 cpm precipi
tated) and are strongly mhibited at <s 1 μg/ml 9 3 mAb clone
2G11 expiesses httle T90/44 (1100 cpm preupilated) and is
only weakly mhibited at the highest 9 3 mAb concentration
As wis to be expected from their Τ helper phenotype all the
clones tested express similar levels of Γ4 antigen [10 11] It
was however unexpected that clonc 2G11 and to a lesser
extent clone 6C7 in addition to T4 express rehtively high
teveis of Γ8 antigen which does not appear to tnterfere with
their helper function With regard to the simultaneous expres
sion of T4 and T8 anttgens in these clones it is of mterest that
in further blocking studies anti T4 mAb but not anti T8 mAb
were found to inhibit the activation of clone 2G11 by Μ leprae
(data not shown) The present data do not show whether the
finding that the two T8+ clones 2G11 and 6C7 also have τ
relativeiy low expression ot T90/44 has a functional signifi
cince All the cell clones tested by the immunoprecipititions
were found to express similar amounls of DRa β and DOa β
Itgurc 3 Incorporated r idioaclivity (tpm " l) in T9Ü/44 and refer
ence anttgens immunoprccipilatcd from surface lodinaled cell clones
2B2 2F10 2G4 2G11 6C7 3E8 (Λ) D class I antigens he tvychain
(MHC I) ß2 microglobulm (ß2M) LFA 1/large subunit [LFA 1(1)]
and Ι ΓΑ 1/small subunit [LFA 1(2)] (B) T90/44 T8 T4 tnnsfernn
leeeptor (TR) The columns in (B) rehtive to those in part (A) of the
figure are scaled up by a faUor of 9 3 The ineorporitcd radioactivity
per 5 x 10 cells is tndicated in all fields bdow the tolumns in units of
cpm
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(data not included in Fig 3) and of transfernn recepiors
(Fig 3) This finding corroborates the above conclusion from
the functional assays that all the clones have a comparable
prohferatjve potential because these surface molecules may be
viewed as markers for the cellular activation State
Furthcrmore since the clones 2G11 (low T9Ü/44) and 4A4
(high T90/44) were denved from the same leprosy patient BC
(DR3 4/DRw52 53/DQw3/DPwl 5) whereas the other clones
were denved from patient R (DR2 3/DRw52/DQwl 2/DPw<>)
it can be concluded that the level of T90/44 expression does not
correlate with that of class II antigens
It is noteworthy that the analysis of the cell surface immuno
fluorescence in the FACS IV yielded results which were ton
sistent with those of the lmmunoprecipitations in Fig 3
Therefore, the amount of radioactivity incorporated into the
vanous cel! surface antigens by the prescnt lodmation protocol
also by this cntenon may be considered a good ipproximation
of their relative amounts when the different cell clones are
compared Α fuither result of the FACS malysis was that the
expression of Γ90/44 in α given cell population is homogene
ous For example the low T90/44 expression in the 2G11 cell
clonc is Juc to the equally low expression in all cells r ithci
than to the presence of positive and negative cclls bec uise only
one Single peak of positive fluorescence is recorded in the
FACS IV immunofluoiescencc profile
3 ** Effects of 9 3 mAb on tytotoxic Τ cell lincs
Three class I restneted CTL (f c HLA AI ind B8 restneted
anti minor Η antigen specific Cl L HLA A2 and B7
restneted Η Υ specific CFL and HLA A2 1 specific alloim
mune CTL [12 13]) were used to investigate whether the
9 3 mAb is capable of interfering with cytotoxic functions It
had been estabhshed by pnor lmmunoprecipitations that these
CTL express simildi amounts of T90/44 as those Μ leprae
activated T^ ciones with high T90/44 expression (sce ibove)
when measured on a per ctll b isis or relative to expression o!
the class I intigens (d it ι not shown) The funetion il elieets oi
the 9 3 mAb and of several reference antibodies on the cellu
lar cytotoxicity was investigated in a CML assay It was found
that the 9 3 mAb in contrast to the reference antibodies
which had vmous inhibitory effects was not capable of intei
fering with the cytotoxic funetion of any of these C Π
(Table 1)
Γ90 44 (9 1 intigen) in I cdl activ itiun 129^
In a further approach to define the regulatory mechanisms in
which T90/44 piays a functional role ihe effects ot the
9 3 mAb on the prohferative rather than the cytotoxie
actiwties of these CTL were investigated The HL Α Α2 1
alloimmune and the H L A A2 restneted Η Υ specific Π Ι
were stimulated m a 5 diy MLR with their specific stimuhtor
cells and co eultured with vanous concentrations of 9 3 mAb
and anti T3 where ifter pH]dThd incot poration was me isured
(Table 2) The prohfcration of both CTL was found not to be
significantly modulated by the 9 3 mAb in contrist to the
pronounced inhibitory effect of (he lnü Π mAb {Ί ible 2)
In further expenments the 9 1 mAb \\ is tested tor its ibilitv
to inhibit natural killer activit> oi antibody dependent eellul ir
cytotoxicity and was found not to inhibit in those iss i\s (d it ι
not shown)
3 4 Lymphocyte transformation tests
First indications that T90/44 h is ι functional lole in 1 cell
aetivition were prowded bv the timling th it 9 mAb
enhances mitogenic responses ot PBL to suboptim tl e incen
trations of P H A or to illo^eneie (ells wheieas no chieet
mitogemc effeet of th t intibod} eould bc dcteeled j^j ί hese
results weic confirmed ind evtended b> H u u i il |~] but ι
direet mitogenic action of 9 3 mAb w is doeununled in ι m o n
lecent report [8] To investig ite this point in moie det nl the
effects of 9 3 mAb and ot se\eril icftrenee intibodies were
studied in a senes of lymphocyte tr msform ition tests c trned
out with PBL of 2 u m t h t e d donois ( T i b l e i ) Mion^
enhancernents of the prohteritive responses to PPD md 1 Γ
(20 30 fold) weie found which support the preuouslv
reported growth enhancement phenomem [i 7] No effect of
9 3 mAb on the cultuie activated b> PHA is detected becausc
the P H A here is used in optimilK ^ctivitinu eoncentr ition
(['S] <ee Sect 2 4 3)
Fhe above transformition tests were carncd out in RPMl 1640
mulium supplemented with li 'V HS [i 7] However when
t'ie PBL weit eultured in RPMI 1640 meditim supplemenled
vvith PCS inste id of HS md uete exposeci to 9 3 mAb vuthout
iny fuither aetivating fauon, ι strong dneet mitogtnie iction
of 9 3 mAb became apparent which ne lrlv equ tlled th tt
found with anti T3 mAb (Tabie 3 last columnj This diieel
mitogenic action of 9 3 mAb is m slnrp contnst with the ab
sence of any aetivition ai equivilent antibodv eoncentr tti( ns
in media supplemented by HS [5 7]
r i b l t 1 E f t e c t s o f 9 1 m A b a n d o f r e f e r e n c e i n t i b o d i L s i n C M 1 e i r r e i l i i l w i t h i l l i i m m u n c U L A A " 1 1 s u b h p e s f x c i h e C 1 1 ( n u l l t \
A 2 1 ) H l Α Λ Ι i n d B K r e s t n e t e d i n n m i n o r l l m i l d e n s p c c i l L C I I ( i n t n i d ι Η \ " ! ) H I Λ Λ " 1 n d B 7 i e M i i U n . 1 n l Ι Π s [ u l i ( 1 1 n !
s p e c i h c t a r n e t c e l l s
H.Y
10 1
Ί ) Effcctor u r g c t LC!I r itio
b) Pt.rccntit,e ot tdrect c d ! KMS ι id [t L
Inhibition ot lysis (in pirenthtsL 1 ,) I \
the Vdnüiih intibodttA i r t ivin is ίΐκ
ratan of tnplic HL t l I t u a Μ R I M I
1640/11" HS
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lab le 2 Eüects oi 9 3 mAb md α Γ3 mAb on tht proliferdtion of Hi Λ A2 restnctcd inti Π Υ C I L ( Ü H Y) ind inti HLA A2 1 llloimmune
CTL (aA2 i) in 5 day MLR with specific tarnet cclls Ihe incorponted [ JH]drhd is givL-n as the mean epm of tnplicatc cultures
CTL
anti H-Y
anti A2 1
mAb
Medium
Antibody concentration
0 001 0 010 0 100 10
9 3 2lblO±346O 24580+ 540 2Π70 ± 640 20?20ΐ 1Μ0 26020+ 585
anti T3 23045 ± 925 24965 ± 1315 $900 ± 250 3085 ± 375 2550 ± 15
9 3 24560+ 280 29SJ0 ± 471 33060 ±5330 28590 ± 2380 37520 + 7135
anb-T3 17675 ± 285 18405 + 605 9265 ± 1550 4953 ± 32 " * $tm*r itf
The antibody concentration dependence and ihe possible role
of monocytic cells in thc dtrect Τ celi activation by 9 3 mAb
were investigatcd PBL of the two donors wer«, depletcd of
monocytes by sorting out cells stained with PdV 10 2 (anti
monocyte) rnAb on the FACS IV The ceils were then eul
tured in medium supplementcd by 10% FCS to reveal the
direct mitogenic acfion of 9 3 mAb Α strong proliferative
response to 9 3 mAb again was found at 5 6 μg/m^ aniibody
and 2 5 x l(f cells/ml wtth PBL the monocyte depleted lym
phocytes did not respond to 9 3 mAb but its mitogenic iction
could bc restored by re adding irradiated autologous PBl to
the punfied iymphocjtes (Table 4) Ihe cel! activation tng
gered by 5 6 μg/ml 9 3 mAb nearly tquals that in ihe α Τ3
mAb or PHA controis
This direct mitogenic action is only found at high antibody cell
ratlos it has practicaliy vamshed already at the fourfold higher
dilution of 9 3 mAb (Table 4) whtre is thc enhancemeni of
growth piomoting Signals is deteeted even at η g/ml 9 3 mAb
[5]
It may be concluded that the mitogenic action of 9 3 mAb
depends on the prestnee of monocytes and is quenched by HS
Α likely cause of the suppression of the mitogenic action in
media supplemcnted by HS is their relativcly high content in
human immunoglobulm molecules It might then be proposed
that the binding of 9 3 mAb to Fc reeeptors of monocytes and
as a consequence the possibie clustering of 190/44 is function
dlly important This hypothesis is further supported by the
recently reported finding that F(ab)2 but not l· h fragments of
9 3 mAb have functional tffects on Γ cclls [17] Howevtr it
cannot be exeluded that the quenching by IIS is at least in part
due to thc presence of matenal which reacts with 9 3 mAb
(e g shed T90/44) [5]
3.5 Γ90/44 expression is mduced in activated Γ cells
Comparative immunoprecipitation studies had revealed that
both the class ί restneted CTL and the class II restneted Μ
leprae activated T|, cell clones express sigmficintly larger
amouts of T90/44 than resting PBL It was thei efore postulated
that Γ90/44 cxpiession is mduced in activated Τ cclls Toinvcs
tigate this hypothesis PBL or two unreiated donors were eul
tured in the presence of optimally activating concentrations of
PHA and (afterday 3) of IL 2 Aliquots of ceils were surface
lodmated at day 0 3 5 and 7 of PHA activition T90/44
together with other representative surface intigens were
irnmunopreupitated from ceü lysates the respective bands
weie cut trom SDS gels and the mcorporated ladiolabel w is
counted it WdS found that the iadioaaivity per cell which is
incorpoiated tnto Ύ90/44 jncreased reguJarJy from day 0 to
day 7 by factors of 6-10 (F-ig 4) Whereas similar results were
observed with DRa β and DQa β and with the transferrm
reeeptor less pronounced increases were found with the LFA
1 or class I antigens The expression of still other surface anti
gens was not affected by the cell acttvation for example thc
rad/oiabel mcorporated into the 4 3 dntjgen [J6] remaincd
practicaliy constant throughout the whole activation penod
(Fig 4)
The suifacc lodination of cells and the lmmunopreopitations
were cirncd out under cartftilly standardized copditions thty
lable 3 L vmphocjtc tr insform ition tests Ϊ fftUs of ) Ί mAh mtl ι I lükixnu. uitibodies oii pro
unrLl ncd donors Α ind Η elicittd by PIIA PPD tnd ! I
r IIIVL responses oi lJEi| isol IILÜ Irom two
Medium
Antt-T3
Arm T4
Anti-T8
Anti LFA-1
9 3"
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
Α
Β
FHA
599Π ± 1198
67135 ± 24169
65810 Je
78490 ±
55913 ±
64803 +
56093 +
67700 +
21840 t
35003 ±
« 613 +
70383 +
1316
3140
559
1944
1122
1354
655
2450
1232
704
PPD
5292 +
16170 ±
147900 ±
127100 +
5988 +
10067 +
4578 ±
11700 ±
618 ±
2668 ±
J07393 +
79780 ±
847
1455
7395
5084
1257
1711
1099
3510
272
1387
8591
15158
ΓΓ
4857 ±
9377 ±
2574
2250
182933 + 31099
167767 ± 10066
1335 ±
6742 4
3522±
4 5 7 5 *
331 ±
1260 ds
814
1618
2360
4666
136
1575
162233 ± 22712
58117 ± 52305
Medium/10% FCS
2 7 3 *
288 ±
19
66
63593 + 636
52 580 i 2629
2S8±
343 ±
138 ±
229 ί
25f±
243 ±
36
58
, 26
31
AI
«3
41330 + 7026
20697 ±1656
a) Ceils of two donors Α ind Β wert,
cultured in RPMI 1640 medium
suppltmentcd by 15% HS (PIIA
PPD TT) or by 10% IXS (Medi
um last column) Mcan epm and
stindird dcviation (triplicatc eul
turcs) of lncorpoi ited p l^
b) 5 6 μβ/ml
Eur J Immunol 1986 16 1289-1296 T90/44 (') 1 intigLn) in 1 celi activ ition
lablc 4 Mitogcmc iction of 9 3 mAb (^  6 ind 1 4 u^ ,/ml tnlibud)) inti Π mAb nid PH \ in LUIIUKS ol I'BI (S Χ II) CLIK \\U1) 1\ inph I
(5 χ K)J cells/wcll) punficd by soiting out monocytic cclls Iroin PBL onllu 1 ACS IV ccll SGULT ilu s imL punlicd l\mp!ioc\tLs (s χ Κ!
well) to which-mtologous nridiätcd PBL (S χ 10 iclK/uül) uorc iddui b ILL iml irr uli ited PB1 (S χ 10'Ldls u J l )
Medmiä Ab)t
' - »t %<•
93·>% . »Λ"
. 'Β -
Ai»rf"3 Α,
Β \
PHA A
Β
BBL·,
*488ι± '41
ft}^5X'547 '
^ >ΚΚ4'
ν
"ΐ49
"«7350 ί 2ΟΪ0"
441S3 ± 2209
§1933 + 1858
58253 + 1165
Lymphocyies
117 ± , 34
1,0Α± 2Q
"»' 223 * ΐϊδ
,-' 9 3 * ^
** 3Ä4 291''
21ί έ 85
Ϊ0 950+ 547
19827 ± 1586
Lymphocytes +
PBL" 1
262 + 52
260 ± 159
'22587 + 2710
21150 ± 1480
' Ζϋ!> ± 366
1 0 9 8 * 121
41183 4 2471
36390 + 1456
43433 + 1303
52743 ± 2109
PBL
232 1
632 ±
8095 +
2092 +
210 ±
88 +
15447 ±
6489 +
20250 ±
13740 ±
16
929
648
209
57
20
927
519
1417
550
a) PBL· - irridutid PBl
b) CillsoftwadonoisA m d H » u u
RPMI 1640 mtüivim Mippkmullu
FCS
L) MLdn cpm ind slindud tlt.M uinn
cullurc^) ül niLorpor Ui„d [ l [|tl I In
d) 3 6 ug/ml
L) l 4 ug/ml
refer to the samt acfivity reference date of P 5I Fui th t rmoi t
microstopic ln&pection confumed that pidctically dl] the ctlls
in the eulture were uniformly traniformed The ladioactivity
mcorporated into a givtn surface antigen thus IS a good
approximation for ihe relative number of its copies per ccil
when the cells of a given donor are compaied thioughout the
activauon penod It may then be concluded that the T9Ü/44
expression increases at least m proportion with tht cell surfacc
arta in the blast transformation in view of the stecpei mertase
of T90/44 when compared to that of class I or LF· Α l il ι ιπηοΐ
e\en be exeluded that the eeli surf ice densitv of fc)()/44 in ιΐκ
PHA blabts is higher than in resting cells
(A)
ftguu 4 Rcl itivt cxprcssion ol· 190/44 iml ol ILILICIUC IHIULUS on
PBL of two donuis IJIL! m ΡΜΛ ictiv ition the inlii,t.ns VM.IL
nnmu!iOi)rLci|j]tat(.d trom iliquots ol suil ici. 10dm ULCI I'HI u d i> 0
3 ^ <ind7 culluitd in the piLScriLi. ol Ρ1ΙΛ ind 112 11K knui ρ irl ol
tht columns rtfers to the cpm ol mcorpoi iled ' 1 in the Inst üunoi
the tot il hcight ol ihc columns refeis to cpm ineorpor itLtl ' 1 in the
second donor (A) LrA 1/lirgc kDi subunit [1 ΓΑ !(!)] md sm ill
subumt [Ι ΓΑ 1(2)] CIHSS 1 antigen heavy eham (MflC 1) f> micro
glohuhn (B) 190/44 4 "Ϊ intigcn(4 3) tnnslerrm iceeptoi (I R) ci iss
II intigens DRa β and DQa β The columns m ρ in (B) iehti\e to
those in pait (A) ol the figurc weie sc ilcd np bv ι i ictoi of 1 Ihe
incoipontcd radioactivity pci *> χ Π)7 eclis of the second donot ire
givcn in il! ficlds below the coHimns in unils ol ipm
4 Concluding remaiks
The number ot the diffcrent 1 edi suttice mtieLiis ilnonjh
which the intracellul u atti\ ititin ρ ithw i\ c m Ix idiiies^ed
and which thereloie um tcti\ itc I cclls inlo piohlci ition is
small At piestnt the Τι/Ή umipltx uul !ΐκ Π Ι mtme.il iri
known to belong to Ihis cl iss oi CLII siui KC molet-ults [ 1 ί|
The present results toetthci vvith the, prcvious iindin^s on the
functional effecls of 9 λ mAb ["> 7 j^ k i\e httk doubt th it
Γ
ι)()/44 also tan recene mitogcnic infomi ition 1 ()0 44 tonn ill\
nKets the csscnti il (.nteii ι \\liieh dehnt ι leceptoi m o l n u k
it is exprtssed it the ccil smi in. buuls a speeihe hiz ind uul is
a consequence changes in LLII tunction are. mc.asi.ucd Α
itceptor funciion of T90/44 therefore c innot bt t.\c!udt.d uul
to search for a physiolocic ligand in fuithu studits mmht bt.
jubtihcd
Thtrc is irm tvidcncc that T90/44 ind tht o/jl hcteioduneiit
Ti aie d stintt gtne produets T h t subunits ot 190 44 e innot be
ltsolved into separate b mds by \ \ inet) ot e k t t r o p h o i t t i t
mttheds whereas Γι tonsisttntl) is rtsoi\ed into u tnti [Hub
units of difftreiU moletul u mass [ 1 2 5 6| Furthtrmoie il
\va found th it T90/44 and [ ί tannot be tomodulattd |7 S
ISj 190/44 therttoic is indtpe.ndtnt üf the l t i t p to i stiuetuie
which appears to b t ihc complt t t antigtn itto,:nition Mtt j I j
11 md> then be tont ludtd th it th t itti\ation throu^h 190 44 is
indeptndent of antigen If the timc pomt m tht 1 teil itti\ ι
tion procebS at whith 190/44 might tunttion is cv ilu itetl tht
tui tht i significant finding tnat 9 1 mAb dircttK oi in tombm ι
tion with phorbol esters inüucts II 2 and IL "* i t t tp to i expies
sion [7 8] has to be tonsidf i t d An> i te tp tor tunttion oi 190
44 tht,π would have to bt pt iced in tht penod btfoit II ] II 2
i t teptor i n l t n t t i o n i! 1 cdl itti\ ttion is \ie\\ed is mol l t ι
ton niiiltisttp sequtnee ol SLICLC>SI\C „iowtti st^n ils I I I \ \ L \ L I
tht prcsentlv a\ailablt d it ι do not tllow tht e melu^ion th ι
tnggtnnti of T90/44 is in obhgitorv sttp in such ι ^cqiience
The actnation through 190/44 lalhti mi^ht icpits tnt m in ι
gtn indtpendent bypass of ihe Τ ι Τ ^  eompkv Μ )de!s oi e.il
actnation pathways based on the latter issumption woukl pre
dict that a p n m a r y activatingsign il i t c t i \ t d b\ tht Ιι "Π e >rn
plex may become modulattd b> the. mput nf setoml m sub
thitshold Signals into actts-,ory retcptoi(s) Priciieilh ill t
the funttional tffetts ot 9 1 m \ b itpoUed if the\ do nt t
prove modeis of the I itltr typt tl It ist ut consistuii w uli it
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Any model of T90/44 function has to take into account the
important finding that the 9.3 mAb can either block or pro-
mote proliferation. The former is found in the Inhibition of the
specific response to M. leprae in the cloned Th cells; the iatter
is clearly documented in the mitogenic effect on resting lym-
phocytes in the presence of monocytic cells, FCS and high
antibody concentrations or in the enhanced responses to PPD,
TT and PHA (Table 3; [5, 7, 8]). This apparent dichotomy of
functional effects is consistent with various modeis. It may be
envisaged that all growth-regulating signals either at the cell
surface or intracellularly ultimately converge on a common
biochemical pathway; if, furthermore, regulated feedback
loops play a role along this pathway, it becomes obvious that
depending on the Status of the System the same receptor
molecule may elicit positive or negative responses. The high
level of expression of T90/44 in activated as compared to rest-
ing cells is likely to be one of the key factors which determine
whether a positive or a negative signal is generated at T90/44.
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